Stem Cell Authority, Ltd. (SCAL)

Market Cap	182.70M +5,213.6%
Revenue (ttm)	3.33M +11,044.2%
Net Income	1.83M
EPS	0.01
Shares Out	12.18B
PE Ratio	2.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	21,740
Open	0.0150
Previous Close	0.0001
Day's Range	0.0150 - 0.0150
52-Week Range	0.0000 - 0.0150
Beta	-1.11
RSI	55.49
Earnings Date	n/a

About Stem Cell Authority

Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of stem cells. It specializes in the collection and cryogenic preservation of the hematopoietic stem cells from the umbilical cord blood; and the Miracle Mesenchymal stem cells from the Wharton’s jelly inside the umbilical cord of a newborn child. The company’s technology enables birthing professionals with a stem cell preservation program to serve their maternity patients in the United States. Stem Cell Authority, Ltd. is based in ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: Carlzo Cardwell
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: SCAL